Amy Holroyd
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Sexual Differentiation and Disorders
Papers in
-
- Protein Degradation and Inhibitors 4
- Cancer therapeutics and mechanisms 1
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Richard S. Houlston (5 shared papers)D. Timothy Bishop (1 shared paper)Janet Shipley (1 shared paper)Clare Turnbull (2 shared papers)Peter Broderick (2 shared papers)Robert Huddart (2 shared papers)Mark T. Drayson (3 shared papers)Kevin Litchfield (2 shared papers)
- Partner nations
- United KingdomNorwayUnited States
In The Last Decade
Amy Holroyd
5 papers receiving 60 citations
Peers
Comparison fields: 5 of 14
- Hematology 30
- Molecular Biology 43
- Genetics 12
- Surgery 17
- Oncology 10
Countries citing papers authored by Amy Holroyd
This map shows the geographic impact of Amy Holroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Holroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Holroyd more than expected).
Fields of papers citing papers by Amy Holroyd
This network shows the impact of papers produced by Amy Holroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Holroyd. The network helps show where Amy Holroyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Holroyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 24 | |
| 2 | 2022 | 23 | |
| 3 | 2023 | 6 | |
| 4 | 2017 | 6 | |
| 5 | 2024 | 2 |
About Amy Holroyd
Amy Holroyd is a scholar working on Molecular Biology, Hematology, Surgery, Oncology and Genetics, having authored 5 papers that have together received 61 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Testicular diseases and treatments (2 papers), Cancer therapeutics and mechanisms (1 paper), Cancer Treatment and Pharmacology (1 paper), Peptidase Inhibition and Analysis (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Hematology (30 citations), Molecular Biology (43 citations), Genetics (12 citations), Surgery (17 citations) and Oncology (10 citations). Amy Holroyd has collaborated with scholars based in United Kingdom, Norway and United States. Frequent co-authors include Richard S. Houlston, D. Timothy Bishop, Janet Shipley, Clare Turnbull, Peter Broderick, Robert Huddart, Mark T. Drayson, Kevin Litchfield, Amy Lloyd and Tom Grotmol. Their work appears in journals such as Blood, Oncotarget and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.